Hans E. Huber

6.3k citations

66 papers · 4.4k indexed · h-index 32

Impact in

Virology top 2%
- HIV Research and Treatment
Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer
- DNA Repair Mechanisms
- DNA and Nucleic Acid Chemistry

Papers in

Genetics 17
- Virus-based gene therapy research 10
- Bacterial Genetics and Biotechnology 6
Molecular Biology 41
- PI3K/AKT/mTOR signaling in cancer 10
- Protein Kinase Regulation and GTPase Signaling 6

Co-authors: C C Richardson Stanley Tabor Deborah Defeo-Jones Raymond E. Jones R. Robinson Stanley F. Barnett George D. Hartman Pearl S. Huang
Journals: Bioorganic & Medicinal Chemistry Letters (15 papers)Journal of Biological Chemistry (10 papers)Molecular and Cellular Biology (6 papers)Gene (3 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

Hans E. Huber

66 papers receiving 4.3k citations

Peers

Countries citing papers authored by Hans E. Huber

Since Specialization

Citations

This map shows the geographic impact of Hans E. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans E. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans E. Huber more than expected).

Fields of papers citing papers by Hans E. Huber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans E. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans E. Huber. The network helps show where Hans E. Huber may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hans E. Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hans E. Huber Line = papers co-authored together Hans E. Huber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cure Science Advances ·อลงกรณ์ สิมลา, Debashish Roy, Selvi Srinivasan, Can Polat, Vladimir A. Vlaskin, Duy‐Khiet Ho, Алексей Федорович Георгиевский, Ashish S. Srivastava, Emma Maack, Jing Zhang, Brandon Pybus, Оксана Химич, Alison Roth, Peter D. Senter, George W. Tyson, Hans E. Huber, David Wesche, Rosemary Rochford, Paul A. Burke, Patrick S. Stayton	2024	3
2	Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer Oncogene ·Vikash Reebye, Kai‐Wen Huang, Vivian Lin, Sheba Jarvis, Rattanachart Sirinil, Stephanie Dorman, حسام حرجان عجاج العيساوي, Pinelopi Andrikakou, Jon Voutila, Pål Sætrom, Paul J. Mintz, Isabella Reccia, John J. Rossi, Hans E. Huber, Robert Habib, Ruth Beale, David C. Blakey, Nagy Habib	2018	73
3	Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer Molecular Therapy ·Jon Voutila, Vikash Reebye, Thomas C. Roberts, Nolan Swain, Pinelopi Andrikakou, David C. Blakey, Robert Habib, Hans E. Huber, Pål Sætrom, John J. Rossi, Nagy Habib	2017	85
4	An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo Cancer Biology & Therapy ·E Gatti, Kathleen Haskell, Bonnie J. Howell, Raymond C. F. Jones, Karen Leander, R. Robinson, Sanika M Thakur, Mark T. Bilodeau, J. M. HOFFMAN, Philip E.J. Sanderson, George D. Hartman, 雅俊柳沢, Thomayant Prueksaritanont, Guoqiang Jiang, Qing‐Bai She, Neal Rosen, Laura Sepp‐Lorenzino, Deborah Defeo-Jones, Hans E. Huber	2010	53
5	Abstract #3714: In vitro and in vivo antitumor activities of MK-2206, a new allosteric Akt inhibitor Cancer Research ·Wei Lu, Nan-Kuang Yi, Lenora J. Davis, Gaozhen Hang, Jennifer Tammam, Harold Hatch, Bart Lutterbach, Christopher Ware, Kathleen Haskell, Patrick Joseph Pardo, Karen Leander, E Gatti, Sanika M Thakur, Kelly Hamilton, Philip E.J. Sanderson, Hans E. Huber, Pradip K. Majumder, Bo‐Sheng Pan	2009	11
6	Allosteric inhibitors of Akt1 and Akt2: A naphthyridinone with efficacy in an A2780 tumor xenograft model Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau, Fatou Niasse Dia, J. M. HOFFMAN, Peter J. Manley, Stanley F. Barnett, Deborah Defeo-Jones, Kathleen Haskell, Raymond E. Jones, Karen Leander, R. Robinson, Anthony M. Smith, Hans E. Huber, George D. Hartman	2008	56
7	Development of Pyridopyrimidines as Potent Akt1/2 Inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhicai Wu, A Gabelmann, Y. Iitsuka, R. Robinson, Sheng Fu, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, Astrid M. Kral, Hans E. Huber, George D. Hartman, Mark T. Bilodeau	2008	23
8	Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, R. Robinson, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, George D. Hartman, Hans E. Huber, Mark E. Duggan, Craig W. Lindsley	2007	38
9	Rapid assembly of diverse and potent allosteric Akt inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhicai Wu, R. Robinson, Sheng Fu, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, Astrid M. Kral, Hans E. Huber, Nancy E. Kohl, George D. Hartman, Mark T. Bilodeau	2007	41
10	Kinesin spindle protein (KSP) inhibitors. Part V: Discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by β-fluorination to overcome cellular efflux by P-glycoprotein Bioorganic & Medicinal Chemistry Letters ·Christopher D. Cox, Michael J. Breslin, David B. Whitman, Paul J. Coleman, R. M. Garbaccio, Mark E. Fraley, Matthew M. Zrada, Carolyn A. Buser, Eileen S. Walsh, Kelly Hamilton, Robert B. Lobell, Weikang Tao, Marc Abrams, Vicki J. South, Hans E. Huber, Nancy E. Kohl, George D. Hartman	2007	39
11	Discovery of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP Cancer Research ·Mark E. Fraley, L. Drumm Myers, Hans Joachim Kreutzer, Li-Na Teng, George D. Hartman, Clécia do Nascimento Cavalcante, Carolyn A. Buser, Weikang Tao, Hans E. Huber, Nancy E. Kohl	2005	1
12	Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao, William Leister, R. Robinson, Stanley F. Barnett, Deborah Defeo-Jones, Raymond E. Jones, George D. Hartman, Joel R. Huff, Hans E. Huber, Mark E. Duggan, Craig W. Lindsley	2005	125
13	Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I Bioorganic & Medicinal Chemistry Letters ·Christopher J. Dinsmore, C. Blair Zartman, Jeffrey M. Bergman, Marc Abrams, Carolyn A. Buser, Joseph Culberson, Joseph P. Davide, Michelle Ellis-Hutchings, Christine Fernandes, Samuel Graham, George D. Hartman, Hans E. Huber, Robert B. Lobell, Scott D. Mosser, R. Robinson, Theresa M. Williams	2004	8
14	The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases Bioorganic & Medicinal Chemistry Letters ·Thomas J. Tucker, Marc Abrams, Carolyn A. Buser, Joseph P. Davide, Michelle Ellis-Hutchings, Christine Fernandes, W. Wayt Gibbs, Samuel Graham, George D. Hartman, Hans E. Huber, Dongming Liu, Robert B. Lobell, William C. Lumma, R. Robinson, John T. Sisko, Anthony M. Smith	2002	13
15	Anions Modulate the Potency of Geranylgeranyl-Protein Transferase I Inhibitors Journal of Biological Chemistry ·Hans E. Huber, R. Robinson, Sanika M Thakur, Deborah D. Nahas, Marc Abrams, Carolyn A. Buser, Robert B. Lobell, D Patrick, Neville J. Anthony, Christopher J. Dinsmore, Samuel Graham, George D. Hartman, William C. Lumma, Theresa M. Williams, David Heimbrook	2001	16
16	Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I Bioorganic & Medicinal Chemistry Letters ·Jeffrey M. Bergman, Marc Abrams, Joseph P. Davide, Ian Greenberg, R. Robinson, Carolyn A. Buser, Hans E. Huber, Kenneth S. Koblan, Nancy E. Kohl, Robert B. Lobell, Samuel Graham, George D. Hartman, Theresa M. Williams, Christopher J. Dinsmore	2001	25
17	Resorcylic Acid Lactones. Naturally Occurring Potent and Sclective Inbibitors. The Journal of Antibiotics ·Annie Zhao, K. S. Nandhanaa, MARINA MOIENA, Rosalind G. Jenkins, Denis R. Patrick, Hans E. Huber, Michael Goetz, Otto D. Hensens, Deborah L. Zink, Dolores Vilella, Anne W. Dombrowski, Russell B. Lingham, Leeyuan Huang	1999	100
18	Small G proteins of two green algae are localized to exocytic compartments and to flagella Plant Molecular Biology ·Hans E. Huber, Kurt Beyser, Stefan Fabry	1996	21
19	Human Papillomavirus Type 16 E7 Protein Inhibits DNA Binding by the Retinoblastoma Gene Product Molecular and Cellular Biology ·Steven M. Stirdivant, Hans E. Huber, Denis R. Patrick, Deborah Defeo-Jones, Venkata Harish, Victor M. Garsky, Allen Oliff, David Heimbrook	1992	2
20	Membrane damaging effect of the delta -endotoxin of Bacillus thuringiensis. Cellular and Molecular Life Sciences ·Kenneth Carpen Young, Peter Lüthy, Hans E. Huber	1980	14

About Hans E. Huber

Hans E. Huber is a scholar working on Genetics, Molecular Biology, Oncology, Virology and Organic Chemistry, having authored 66 papers that have together received 4.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (10 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Cancer-related Molecular Pathways (9 papers), Quinazolinone synthesis and applications (9 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Synthesis and Biological Evaluation (6 papers), Bacteriophages and microbial interactions (6 papers) and Bacterial Genetics and Biotechnology (6 papers). The work is most often cited by research in Virology (314 citations), Molecular Biology (3.2k citations), Oncology (835 citations), Cell Biology (446 citations) and Organic Chemistry (748 citations). Hans E. Huber has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include C C Richardson, Stanley Tabor, Deborah Defeo-Jones, Raymond E. Jones, R. Robinson, Stanley F. Barnett, George D. Hartman, Pearl S. Huang, Paula J. Goodhart and David Heimbrook. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Molecular and Cellular Biology, Gene and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact